Cargando…

Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice

BACKGROUND: The impairment of endothelium‐dependent vasodilation, increased endothelial permeability, and glycocalyx degradation are all important pathophysiological components of endothelial dysfunction. However, it is still not clear whether in atherosclerosis, glycocalyx injury precedes other fea...

Descripción completa

Detalles Bibliográficos
Autores principales: Bar, Anna, Targosz‐Korecka, Marta, Suraj, Joanna, Proniewski, Bartosz, Jasztal, Agnieszka, Marczyk, Brygida, Sternak, Magdalena, Przybyło, Magdalena, Kurpińska, Anna, Walczak, Maria, Kostogrys, Renata B., Szymonski, Marek, Chlopicki, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475045/
https://www.ncbi.nlm.nih.gov/pubmed/30866689
http://dx.doi.org/10.1161/JAHA.118.011171
_version_ 1783412701217685504
author Bar, Anna
Targosz‐Korecka, Marta
Suraj, Joanna
Proniewski, Bartosz
Jasztal, Agnieszka
Marczyk, Brygida
Sternak, Magdalena
Przybyło, Magdalena
Kurpińska, Anna
Walczak, Maria
Kostogrys, Renata B.
Szymonski, Marek
Chlopicki, Stefan
author_facet Bar, Anna
Targosz‐Korecka, Marta
Suraj, Joanna
Proniewski, Bartosz
Jasztal, Agnieszka
Marczyk, Brygida
Sternak, Magdalena
Przybyło, Magdalena
Kurpińska, Anna
Walczak, Maria
Kostogrys, Renata B.
Szymonski, Marek
Chlopicki, Stefan
author_sort Bar, Anna
collection PubMed
description BACKGROUND: The impairment of endothelium‐dependent vasodilation, increased endothelial permeability, and glycocalyx degradation are all important pathophysiological components of endothelial dysfunction. However, it is still not clear whether in atherosclerosis, glycocalyx injury precedes other features of endothelial dysfunction or these events coincide. METHODS AND RESULTS: Herein, we demonstrate that in 4‐ to 8‐week‐old apolipoprotein E/low‐density lipoprotein receptor‐deficient mice, at the stage before development of atherosclerotic plaques, impaired acetylcholine‐induced vasodilation, reduced NO production in aorta, and increased endothelial permeability were all observed; however, flow‐mediated dilation in the femoral artery was fully preserved. In 4‐week‐old mice, glycocalyx coverage was reduced and endothelial stiffness was increased, whereas glycocalyx length was significantly decreased at 8 weeks of age. Early changes in endothelial function were also featured by increased plasma concentration of biomarkers of glycocalyx disruption (endocan), biomarkers of endothelial inflammation (soluble vascular cell adhesion molecule 1), increased vascular permeability (angiopoietin 2), and alterations in hemostasis (tissue plasminogen activator and plasminogen activator inhibitor 1). In 28‐week‐old mice, at the stage of advanced atherosclerotic plaque development, impaired NO production and nearly all other features of endothelial dysfunction were changed to a similar extent, compared with the preatherosclerotic plaque phase. The exceptions were the occurrence of acetylcholine‐induced vasoconstriction in the aorta and brachiocephalic artery, impaired flow‐mediated vasodilation in the femoral artery, and further reduction of glycocalyx length and coverage with a concomitant further increase in endothelial permeability. CONCLUSIONS: In conclusion, even at the early stage before the development of atherosclerotic plaques, endothelial dysfunction is a complex multifactorial response that has not been previously appreciated.
format Online
Article
Text
id pubmed-6475045
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-64750452019-04-24 Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice Bar, Anna Targosz‐Korecka, Marta Suraj, Joanna Proniewski, Bartosz Jasztal, Agnieszka Marczyk, Brygida Sternak, Magdalena Przybyło, Magdalena Kurpińska, Anna Walczak, Maria Kostogrys, Renata B. Szymonski, Marek Chlopicki, Stefan J Am Heart Assoc Original Research BACKGROUND: The impairment of endothelium‐dependent vasodilation, increased endothelial permeability, and glycocalyx degradation are all important pathophysiological components of endothelial dysfunction. However, it is still not clear whether in atherosclerosis, glycocalyx injury precedes other features of endothelial dysfunction or these events coincide. METHODS AND RESULTS: Herein, we demonstrate that in 4‐ to 8‐week‐old apolipoprotein E/low‐density lipoprotein receptor‐deficient mice, at the stage before development of atherosclerotic plaques, impaired acetylcholine‐induced vasodilation, reduced NO production in aorta, and increased endothelial permeability were all observed; however, flow‐mediated dilation in the femoral artery was fully preserved. In 4‐week‐old mice, glycocalyx coverage was reduced and endothelial stiffness was increased, whereas glycocalyx length was significantly decreased at 8 weeks of age. Early changes in endothelial function were also featured by increased plasma concentration of biomarkers of glycocalyx disruption (endocan), biomarkers of endothelial inflammation (soluble vascular cell adhesion molecule 1), increased vascular permeability (angiopoietin 2), and alterations in hemostasis (tissue plasminogen activator and plasminogen activator inhibitor 1). In 28‐week‐old mice, at the stage of advanced atherosclerotic plaque development, impaired NO production and nearly all other features of endothelial dysfunction were changed to a similar extent, compared with the preatherosclerotic plaque phase. The exceptions were the occurrence of acetylcholine‐induced vasoconstriction in the aorta and brachiocephalic artery, impaired flow‐mediated vasodilation in the femoral artery, and further reduction of glycocalyx length and coverage with a concomitant further increase in endothelial permeability. CONCLUSIONS: In conclusion, even at the early stage before the development of atherosclerotic plaques, endothelial dysfunction is a complex multifactorial response that has not been previously appreciated. John Wiley and Sons Inc. 2019-03-14 /pmc/articles/PMC6475045/ /pubmed/30866689 http://dx.doi.org/10.1161/JAHA.118.011171 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Bar, Anna
Targosz‐Korecka, Marta
Suraj, Joanna
Proniewski, Bartosz
Jasztal, Agnieszka
Marczyk, Brygida
Sternak, Magdalena
Przybyło, Magdalena
Kurpińska, Anna
Walczak, Maria
Kostogrys, Renata B.
Szymonski, Marek
Chlopicki, Stefan
Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title_full Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title_fullStr Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title_full_unstemmed Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title_short Degradation of Glycocalyx and Multiple Manifestations of Endothelial Dysfunction Coincide in the Early Phase of Endothelial Dysfunction Before Atherosclerotic Plaque Development in Apolipoprotein E/Low‐Density Lipoprotein Receptor‐Deficient Mice
title_sort degradation of glycocalyx and multiple manifestations of endothelial dysfunction coincide in the early phase of endothelial dysfunction before atherosclerotic plaque development in apolipoprotein e/low‐density lipoprotein receptor‐deficient mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475045/
https://www.ncbi.nlm.nih.gov/pubmed/30866689
http://dx.doi.org/10.1161/JAHA.118.011171
work_keys_str_mv AT baranna degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT targoszkoreckamarta degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT surajjoanna degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT proniewskibartosz degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT jasztalagnieszka degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT marczykbrygida degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT sternakmagdalena degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT przybyłomagdalena degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT kurpinskaanna degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT walczakmaria degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT kostogrysrenatab degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT szymonskimarek degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice
AT chlopickistefan degradationofglycocalyxandmultiplemanifestationsofendothelialdysfunctioncoincideintheearlyphaseofendothelialdysfunctionbeforeatheroscleroticplaquedevelopmentinapolipoproteinelowdensitylipoproteinreceptordeficientmice